tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Compare Kymera Therapeutics (KYMR) vs. Competitors

Compare
412 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$69.93
$5.52B
-19.44
58.11%
21 Buy
1 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$83.10
$5.20B
131.20
119.84%
11 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$21.75
$2.75B
73.26
-29.29%
11 Buy
5 Hold
0 Sell
Moderate Buy
Crinetics Pharmaceuticals
$53.18
$5.45B
-11.73
35.66%
12 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$15.86
$1.13B
-4.77
-66.17%
9 Buy
1 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
69.93
28.71
69.65%
PTGX
Protagonist Therapeutics
83.10
44.74
116.63%
APLS
Apellis Pharmaceuticals
21.75
-8.04
-26.99%
CRNX
Crinetics Pharmaceuticals
53.18
14.97
39.18%
AKRO
MLTX
MoonLake Immunotherapeutics
15.86
-29.03
-64.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts